Results 21 to 30 of about 9,985 (145)
The graphical abstract summarizes the laboratory characterization of Naganishia uzbekistanensis strain CY11558. The isolate shows distinct colony morphology, globular yeast cells with a fibrillar surface network under scanning electron microscopy, and a weakly positive cryptococcal antigen reaction.
Xin Fan +7 more
wiley +1 more source
International audienceObjectives: To describe micafungin pharmacokinetic (PK) alterations of sepsis induced in piglets and to determine whether the porcine septic model is able to predict the PK of micafungin in septic patients at the plasma and ...
Muller, Laurent +8 more
core +1 more source
We report our single‐center experience of transplant outcomes with a busulfan, fludarabine and melphalan‐based conditioning regimen for children < 18 years of age. The regimen was shown to be well tolerated and effective for heavily pretreated children with high‐risk myeloid malignancies prior to allogeneic hematopoietic stem cell transplant.
Mayank Dhamija +6 more
wiley +1 more source
Micafungin prophylaxis for acute leukemia patients undergoing induction chemotherapy [PDF]
Background Micafungin is a well-tolerated and effective prophylactic antifungal agent used in hematologic diseases. In this prospective trial, we evaluated the efficacy and safety of prophylactic micafungin during first induction chemotherapy in patients
Sung-Soo Yoon +22 more
core +1 more source
Persistent candida arthritis successfully treated with micafungin instillation and surgery. A case report [PDF]
We report a rare case of C. krusei knee arthritis treated with instillation of micafungin and arthroscopy. A 49-year-old man hospitalized for treatment of Acute Myeloid Leukemia developed knee arthritis with C. krusei.
van Egmond, J.C. (Jeroen C.) +7 more
core +1 more source
An Update on Invasive Fungal Infections in Solid Organ Transplant Recipients
ABSTRACT Invasive fungal infections (IFI) remain a significant infection‐related complication in solid organ transplant recipients (SOTRs), the incidence of which has not changed overtime. With a focus on studies and data published after 2019, this narrative review provides an update on the epidemiology and prevention of IFIs in SOTRs and highlights ...
Tina Marinelli, Shahid Husain
wiley +1 more source
Micafungin Treatment Schedule.
Micafungin Treatment Schedule.
Joris Veltman (431438) +10 more
core +1 more source
Among 346 liver transplant recipients, rural residence conferred a 3.3‐fold higher risk of cryptococcal infection — a novel finding suggesting environmental exposure or healthcare access barriers may drive susceptibility. Triple immunosuppression and longer waitlist duration were additional risk factors, with very early infection carrying the worst ...
Rachel Sigler +11 more
wiley +1 more source
A dolgozat a micafungin in vitro aktivitását muatatja be négy Candida dubliniensis izolátum ellen humán szérum jelenlétében.Biológia, Molekuláris biológia szakirányBSc ...
Barta, Réka Edit
core
ABSTRACT The approval requirements in new regions that do not require domestic clinical data and the clinical data evaluation of multi‐regional clinical trials (MRCTs) and foreign clinical trials (FCTs) in the Japanese approval review processes for antimicrobial medicines were explored.
Rumiko Shimazawa, Masayuki Ikeda
wiley +1 more source

